MondayDec 28, 2020 2:20 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) on Track to Leverage Psychedelics to Target Depression

Cybin (NEO: CYBN), a mushroom life science company, is set to leverage opportunity amid growing research that demonstrates the significant role psilocybin could play in alleviating symptoms of major depression. According to a recent study conducted by Johns Hopkins Medicine and published in “JAMA Psychiatry,” only two doses of psilocybin accompanied with psychotherapy may lead to significant reductions in symptoms in adults with major depression (https://ibn.fm/ZpmzM). “The magnitude of the effect we saw was about four times larger than what clinical trials have shown for traditional antidepressants on the market,” stated Alan Davis, PhD., adjunct assistant professor of psychiatry and…

Continue Reading

MondayDec 28, 2020 2:00 pm

QualityStocksNewsBreaks – Net Element Inc. (NASDAQ: NETE) Positioned Amid Surging Demand in EV Space

Net Element (NASDAQ: NETE), a financial technology company in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through a pending merger with privately-held Mullen Technologies Inc., is poised as the EV sector has seen a sharp uptick in consumer demand and investor interest. Rising demand is driven by a combination of improved sector fundamentals coupled with positive industry news. A recent article discussing the company reads, “A potential combined Net Element-Mullen Technologies entity plans to leverage upon the surge in consumer demand within the electric vehicle space through the launch of its initial…

Continue Reading

MondayDec 28, 2020 1:09 pm

ev Transportation Services Inc. Announces Launch of 2021 FireFly ESV

New EV designed to meet needs of essential services transportation market Vehicle updated with maintainability in mind, retains the best of previous models but includes enhanced features and accessories Improvements were focused on quality, driver comfort and creating a wide variety of rear-bed accessory options designed to fit user needs ev Transportation Services, a specialty vehicle manufacturer that produces purpose-built, all-electric, lightweight commercial utility vehicles and fleet-management solutions, has announced the launch of its new 2021 FireFly ESV (https://ibn.fm/QIkgs). The FireFly ESV(r) was created to meet the requirements of the essential services transportation and urban mobility markets, which is estimated to…

Continue Reading

MondayDec 28, 2020 12:48 pm

SRAX Inc. (SRAX) Hosts LD Micro’s 13th Annual Main Event on Sequire Platform; Investment World Eyes Micro-Caps

Analysts recommending small cap stocks for both growth and value amid large cap overvaluations, decreased momentum SRAX subsidiary LD Micro hosted 13th Annual Main Event featuring nearly 250 prominent and emerging micro-cap companies Two-day virtual conference was hosted on SRAX’s Sequire platform from December 14-15, 2020 2 million+ active small cap investors invited from LD Micro’s loyal investor base Large cap technology growth stocks like Amazon and Tesla have seen a massive wave of investor momentum as a result of COVID-19. The resulting overvaluations and decreased momentum in recent weeks, however, are prompting some analysts to recommend a shift back…

Continue Reading

MondayDec 28, 2020 12:03 pm

Innovative Payment Solutions Inc. (IPSI) Ideally Positioned as Blockchain Sees Growing Adoption, Acceptance

Global pandemic fuels development, acceptance of digital technologies, including blockchain HBR article reports that blockchain solutions have been repurposed, unleashed to address challenges Innovative Payment Solutions Inc. simplifies payments and transfers; currently working on creating all-in-one digital payment solution: IPSIPay The impact of COVID-19 has been seen and felt far beyond the health-care industry, reaching into sectors that may not seem to be relatable. Yet the global pandemic has fueled the development and acceptance of digital technologies that offer the security and stability the world is looking for right now. One of those technologies — blockchain — seems particularly well…

Continue Reading

MondayDec 28, 2020 11:42 am

Friendable Inc. (FDBL) Fan Pass Champions Trends, Bridges Gap Between Fans and Artists in Post-COVID World

“Rolling Stone” article outlines key trends that will shape entertainment industry moving forward. As consumer behavior changes, digital becomes key to enabling engagement between artists and fans. Digital champion Friendable appears ideally positioned as industry transitions to digital technologies. In a recent “Rolling Stone” article titled “14 Reasons the Entertainment Industry Will Look Different in 2021,” the popular magazine outlines major trends that will shape the entertainment industry in 2021. Given that industry outlook, Friendable (OTC: FDBL) and its innovative Fan Pass platform seem ideally positioned to benefit. Fourteen entertainment business leaders were interviewed in the article and invited to…

Continue Reading

MondayDec 28, 2020 11:12 am

GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) Looks to Thrive as Specialist Forecasts Bright Future for Junior Mining

Mining industry specialist expects next year to be busy for junior miners after temporary halt due to pandemic Junior miners likely to start 2021 with better financing prospects; exploration expected to resume GOH well placed to capitalize on expected junior boom As the metal exploration boom elevates the junior mining industry's outlook, Canada-based GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF) seems well positioned to leverage the favorable environment that industry experts forecast for 2021 (https://ibn.fm/tFPOm). In a panel discussion hosted by Mines and Money, the leading international event series for capital-raising and mining investment, Jessie Chen of Long State Investment asserted…

Continue Reading

MondayDec 28, 2020 11:09 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Featured in Syndicated Broadcast

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers CNS Pharmaceuticals’ Investigational New Drug (“IND”) application for its lead product candidate, Berubicin, for the treatment of Glioblastoma Multiforme (“GBM”). The IND is now approved and in effect as filed with the U.S. Food and Drug…

Continue Reading

MondayDec 28, 2020 10:33 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Pricing of $26M Registered Direct Offering

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, has announced its entry into definitive agreements with investors for the purchase and sale of 6,265,063 of Foresight’s American Depositary Shares (“ADSs”), each at a price of $4.15, per a registered direct offering. The company will secure approximately $26 million in gross proceeds before deducting placement agent fees and other estimated offering expenses. Foresight intends to use the net proceeds for working capital and other general corporate purposes. The closing of the registered direct offering is expected to take place on or about Dec. 30, 2020, subject…

Continue Reading

MondayDec 28, 2020 10:08 am

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures $12M in Registered Direct Offering

Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, has announced the closing of its registered direct offering of 3,116,884 shares of its common stock with a single health care-dedicated institutional investor. Genprex secured gross proceeds of $12 million, before deducting commissions and estimated expenses, with the offering priced at-the-market under Nasdaq rules at a price of $3.85 per share. “We believe that the closing of this transaction with a single, health care-dedicated institutional investor is further evidence that the potential of our gene therapies for cancer and diabetes is gaining recognition within the community…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered